| Article
In a news release last week, Boston Scientific Corporation, Marlborough, MA, announced FDA approval for its Spectra WaveWriter Spinal Cord Stimulator (SCS) for the management of chronic pain. The Company describes it as “…the first and only system approved by the FDA to simultaneously provide...
| Article
Cannabis as a pharmacological agent has been used for centuries. It's been described in China, in Asian countries dating back to well before the BC era. Ultimately it made its way to the United States where it actually was made available to patients until it was outlawed in the 1930s and '40s. And...
| Article
It has been established that developmental language delay is more common among boys than girls. But a new study suggests that this female advantage may be erased—and even reversed—if the mother has used acetaminophen during pregnancy. Researchers from the Icahn School of Medicine at Mount Sinai...
| Article
Researchers at the University of North Carolina School of Medicine, supported by collaborating scientists from other institutions, have reported major new insights that may illuminate the route to opioids that relieve pain without provoking the adverse effects that underlie the current opioid...
| Article
A study conducted by researchers at the Centers for Disease Control and Prevention sheds new light on national patterns for opioid prescribing to US patients who are below age 65 and on disability. The survey included data from 2014 on some 3.5 million Medicare Part D recipients who were medically...
| Article
In a press release issued yesterday, Neumentum, an emerging entity in the pharmaceutical industry, announced new steps in its efforts to advance non-opioid drug candidates for the treatment of postsurgical and acute pain without the opioid-related risks of abuse, misuse and diversion. Specifically...
| Video
Jessica Geiger-Hayes, a pharmacist from Ohio, answers our questions on opioids, healthcare, patient vs practitioner goals, and more, in this interview from PAINWeek 2017.
| Article
Building on 2 decades of past research, scientists from the Florida campus to The Scripps Research Institute (TSRI) have announced noteworthy progress in the search for a new opioid that delivers the analgesic equivalent of morphine without the major adverse effect of respiratory depression...
| Article
We certainly know that constipation is a reliably experienced side effect from opioid therapy. And I'm sure most everyone has been constipated at some point in their life. It's certainly not a great topic to talk about, but it's very uncomfortable. It makes people nauseated. Just really makes them...
| Article
A study conducted by researchers from Stanford University seeks to enhance our understanding of the experience of pain among women, who have undergone vaginal delivery, in the period after they have been discharged from the hospital. Lead author Ryu Komatsu, MD, a physician anesthesiologist at...